NCT03173092 2026-03-18A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)TakedaPhase 4 Active not recruiting141 enrolled
NCT03829371 2025-12-03STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMAUniversity of Turin, ItalyPhase 4 Active not recruiting450 enrolled